Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuichi Maeda

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Plos One|May 9, 2019
Drug tolerability and reasons for discontinuation of seven biologics in elderly patients with rheumatoid arthritis -The ANSWER cohort studyKosuke Ebina, Motomu Hashimoto, Wataru Yamamoto, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 23, 2016
Dysbiosis Contributes to Arthritis Development via Activation of Autoreactive T Cells in the IntestineYuichi Maeda, Takashi Kurakawa, Eiji Umemoto, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 25, 2024
CCL19-Positive Lymph Node Stromal Cells Govern the Onset of Inflammatory Arthritis via Tropomyosin Receptor KinaseFabian Schälter, Vugar Azizov, Michael Frech, et al.
Annals of the Rheumatic Diseases|August 24, 2021
Metagenome-wide association study revealed disease-specific landscape of the gut microbiome of systemic lupus erythematosus in JapaneseYoshihiko Tomofuji, Yuichi Maeda, Eri Oguro-Igashira, et al.
Rheumatology (Oxford, England)|October 24, 2025
Effect of treat-to-target strategies on maternal and neonatal outcomes of rheumatoid arthritis: a multicentre real-world ANSWER cohort studyYuri Hiramatsu, Takuya Kotani, Eri Nakamura, et al.
Clinical Rheumatology|January 30, 2021
Drug retention of sarilumab, baricitinib, and tofacitinib in patients with rheumatoid arthritis: the ANSWER cohort studyKosuke Ebina, Toru Hirano, Yuichi Maeda, et al.
Nature|January 25, 2019
GPR31-dependent dendrite protrusion of intestinal CX3CR1<sup>+</sup> cells by bacterial metabolitesNaoki Morita, Eiji Umemoto, Setsuko Fujita, et al.
BMC Infectious Diseases|June 24, 2022
Longitudinal alterations of the gut mycobiota and microbiota on COVID-19 severityYuichi Maeda, Daisuke Motooka, Takahiro Kawasaki, et al.
Annals of the Rheumatic Diseases|January 10, 2023
Genomic repertoires linked with pathogenic potency of arthritogenic <i>Prevotella copri</i> isolated from the gut of patients with rheumatoid arthritisTakuro Nii, Yuichi Maeda, Daisuke Motooka, et al.
Arthritis Research & Therapy|March 25, 2023
Gut dysbiosis is associated with aortic aneurysm formation and progression in Takayasu arteritisYusuke Manabe, Tomohiko Ishibashi, Ryotaro Asano, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Plos One|May 9, 2019
Drug tolerability and reasons for discontinuation of seven biologics in elderly patients with rheumatoid arthritis -The ANSWER cohort studyKosuke Ebina, Motomu Hashimoto, Wataru Yamamoto, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 23, 2016
Dysbiosis Contributes to Arthritis Development via Activation of Autoreactive T Cells in the IntestineYuichi Maeda, Takashi Kurakawa, Eiji Umemoto, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 25, 2024
CCL19-Positive Lymph Node Stromal Cells Govern the Onset of Inflammatory Arthritis via Tropomyosin Receptor KinaseFabian Schälter, Vugar Azizov, Michael Frech, et al.
Annals of the Rheumatic Diseases|August 24, 2021
Metagenome-wide association study revealed disease-specific landscape of the gut microbiome of systemic lupus erythematosus in JapaneseYoshihiko Tomofuji, Yuichi Maeda, Eri Oguro-Igashira, et al.
Rheumatology (Oxford, England)|October 24, 2025
Effect of treat-to-target strategies on maternal and neonatal outcomes of rheumatoid arthritis: a multicentre real-world ANSWER cohort studyYuri Hiramatsu, Takuya Kotani, Eri Nakamura, et al.
Clinical Rheumatology|January 30, 2021
Drug retention of sarilumab, baricitinib, and tofacitinib in patients with rheumatoid arthritis: the ANSWER cohort studyKosuke Ebina, Toru Hirano, Yuichi Maeda, et al.
Nature|January 25, 2019
GPR31-dependent dendrite protrusion of intestinal CX3CR1<sup>+</sup> cells by bacterial metabolitesNaoki Morita, Eiji Umemoto, Setsuko Fujita, et al.
BMC Infectious Diseases|June 24, 2022
Longitudinal alterations of the gut mycobiota and microbiota on COVID-19 severityYuichi Maeda, Daisuke Motooka, Takahiro Kawasaki, et al.
Annals of the Rheumatic Diseases|January 10, 2023
Genomic repertoires linked with pathogenic potency of arthritogenic <i>Prevotella copri</i> isolated from the gut of patients with rheumatoid arthritisTakuro Nii, Yuichi Maeda, Daisuke Motooka, et al.
Arthritis Research & Therapy|March 25, 2023
Gut dysbiosis is associated with aortic aneurysm formation and progression in Takayasu arteritisYusuke Manabe, Tomohiko Ishibashi, Ryotaro Asano, et al.
Pageof 8